CanSino moved the inhaled formulation ... which is running a small trial of its mRNA-based candidate and the AstraZeneca/Oxford University vaccine to see if they can be delivered to the lungs ...

AstraZeneca's share price ticked up by ... from researchers in China on another adenoviral vector-based vaccine developed by CanSino Biologics, which also generated antibody and T cell responses ...

those who are not vaccinated by these pharmaceutical companies or with these vaccines are denied entry or are not accepted. So we do nothing if we vaccinate with Cansino or AstraZeneca at the border ...

Today, there are almost a dozen vaccines endorsed around the world. The most widely used are: Pfizer, Moderna, AstraZeneca, Sputnik V, Janssen, Cansino, Sinopharm, and CoronaVac. However ...

The head of the agency, Alonso Pérez Rico, reminded that the Cansino vaccines are effective ... So far the vaccines that have been authorized in the United States are Pfizer, Johnsson, AstraZeneca, ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

The reason that the AstraZeneca vaccine can cause thrombosis is in a small protein called platelet factor 4 (FP4), according to two investigations published in The New England Journal of Medicine.

Abdala thus joined the list of vaccines already allowed within Mexico by Copefris: Pfizer-BioNTech, AstraZeneca, CanSino Biologics, Sputnik V, Sinovac, Covaxin, Janssen (Johnson & Johnson ...

On April 30, AstraZeneca admitted that the vaccine, sold under the name Vaxzevria, can cause fatal blood clots and low platelet counts, also known as thrombosis syndrome with thrombocytopenia ...

“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...

The pharmaceutical giant AstraZeneca 's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...